| Therapeutic delivery specifications identified through compartmental analysis of a mesenchymal stromal cell-immune reaction M Li, D Khong, LY Chin, A Singleton, B Parekkadan Scientific reports 8 (1), 6816, 2018 | 25 | 2018 |
| Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs LY Chin, C Carroll, S Raigani, DM Detelich, SN Tessier, GR Wojtkiewicz, ... Plos one 14 (12), e0225222, 2019 | 10 | 2019 |
| Orthogonal potency analysis of mesenchymal stromal cell function during ex vivo expansion D Khong, M Li, A Singleton, LY Chin, S Mukundan, B Parekkadan Experimental cell research 362 (1), 102-110, 2018 | 10 | 2018 |
| Closed loop bioreactor system for the ex vivo expansion of human T cells M Li, LY Chin, S Shukor, A Tamayo, MV Maus, B Parekkadan Cytotherapy 21 (1), 76-82, 2019 | 6 | 2019 |
| Stromalized microreactor supports murine hematopoietic progenitor enrichment D Khong, M Li, A Singleton, LY Chin, B Parekkadan Biomedical microdevices 20, 1-9, 2018 | 4 | 2018 |
| An engineered biomarker system to monitor and modulate immune clearance of cell therapies A Singleton, D Khong, LY Chin, S Mukundan, M Li, B Parekkadan Cytotherapy 19 (12), 1537-1545, 2017 | 2 | 2017 |
| Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression M Li, LY Chin, S Shukor, AG Tamayo, MV Maus, B Parekkadan Autoimmunity 52 (3), 102-107, 2019 | 1 | 2019 |
| In Vivo Activity of Genetically Modified Cells Preseeded in Rat Vascularized Composite Allografts CB Taveau, AG Lellouch, LY Chin, O Mamane, P Tratnig-Frankl, ... Transplantation Proceedings 53 (5), 1751-1755, 2021 | | 2021 |
| Ex Vivo Characterization and Delivery of Stromal Cell Secreted Signaling to Attenuate T-Cell Activation M Li, LY Chin, B Parekkadan MOLECULAR THERAPY 26 (5), 356-356, 2018 | | 2018 |
